ArticleJournal of obstetrics and gynaecology of India2025
Reference Range of Thyroid Hormones in Pregnancy: Customization Needed for Pregnant Women in India.
Article in Journal of obstetrics and gynaecology of India, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The precise interpretation of thyroid function tests during pregnancy needs population-based trimester-specific data among pregnant women. This study was to determine trimester-specific reference range for free triiodothyronine (FT3), free thyroxine (FT4) and thyrotropin (TSH) among pregnant women in India. Methods: In this prospective observational study, asymptomatic pregnant women with single fetus were enrolled from each trimester. Serum FT3, FT4, TSH and anti-thyroperoxidase (anti-TPO) antibodies were estimated using electrochemiluminescence technique. Results: Among 918 pregnant women, 82 women were excluded due to the presence of anti-TPO antibodies (76) and overt hypothyroidism (6). Among the remaining 836 women, 279 (33.3%) were in first trimester, 309 (36.9%) in second and 248 (29.6%) in third trimester. The 5th and 95th percentile values for each trimester were used as reference ranges. For all three hormones, the reference ranges for the first, second and third trimesters were: FT3 (1.59-3.64, 1.60-3.50 and 1.44-3.28 pg/dl), FT4 (0.64-1.12, 0.64-1.05 and 0.60-1.01 ng/dl) and TSH (0.21-4.95, 0.23-4.90 and 0.14-4.59 µIU/ml). The mean and median values for TSH between each trimester showed no statistically significant difference. No specific trend was seen for FT3 and TSH with advancing gestation. FT4 showed a decreasing trend with advancing trimester (P value: first versus second = 0.01, first versus third = 0.00003 and second versus third = 0.004). The reference range ( Conclusion: The trimester-specific reference levels of TSH among pregnant women from India are significantly higher than 4 mIU/L (American Thyroid Association 2017).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.